Latest News
HOPA Endorses ISOPP & UICC Statement on Ensuring International Cancer Drug Quality and Equity
ISOPP and UICC recently released a statement calling for quality and equity of cancer treatments in sub-Saharan Africa. HOPA has joined with oncology and pharmacy organizations worldwide to endorse their statement.
A Journey of a Thousand Miles Begins with a Single Step Navigating the Path to a Leadership Position
In this personal reflection from the latest issue of HOPA News, Mary Walters, PharmD, BCOP, and Peter Stuessy, PharmD, BCOP, compare and contrast their journeys into leadership roles - and what advice they would give others on their own leadership paths.
Record-Breaking Hill Day Participation Brings HOPA Advocacy, Education to D.C.
HOPA members and staff were hard at work in the nation's capital for HOPA Hill Day on Tuesday, Sept. 30, discussing the hem/onc pharmacy profession and the important issues facing optimized cancer care across the nation.
Leading Cancer Organizations Launch New Patient Education Sheets Website
The new Patient Education Sheets (PES) website is here! Created by NCODA, HOPA, ONS, and ACCC, this updated platform replaces the OCE and IVE websites, offering over 300 trusted, patient-friendly resources to support cancer care.
Explore more from HOPA
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously
